101 related articles for article (PubMed ID: 21267505)
21. Identification of a UDP-Gal: GlcNAc-R galactosyltransferase activity in Escherichia coli VW187.
Montoya-Peleaz PJ; Riley JG; Szarek WA; Valvano MA; Schutzbach JS; Brockhausen I
Bioorg Med Chem Lett; 2005 Feb; 15(4):1205-11. PubMed ID: 15686943
[TBL] [Abstract][Full Text] [Related]
22. Roles of individual enzyme-substrate interactions by alpha-1,3-galactosyltransferase in catalysis and specificity.
Zhang Y; Swaminathan GJ; Deshpande A; Boix E; Natesh R; Xie Z; Acharya KR; Brew K
Biochemistry; 2003 Nov; 42(46):13512-21. PubMed ID: 14621997
[TBL] [Abstract][Full Text] [Related]
23. Thiosugar nucleotide analogs: synthesis of 5'-(2,3,4-tri-O-acetyl-6-S-acetyl-6-thio-alpha-D-galactopyranosyl diphosphate).
Elhalabi J; Rice KG
Carbohydr Res; 2002 Nov; 337(21-23):1935-40. PubMed ID: 12433459
[TBL] [Abstract][Full Text] [Related]
24. Novel aspects of interaction between UDP-gal and GlcNAc beta-1,4-galactosyltransferase: transferability and remarkable inhibitory activity of UDP-(mono-O-methylated gal), UDP-Fuc and UDP-man.
Endo T; Kajihara Y; Kodama H; Hashimoto H
Bioorg Med Chem; 1996 Nov; 4(11):1939-48. PubMed ID: 9007278
[TBL] [Abstract][Full Text] [Related]
25. A nonionic inhibitor with high specificity for the UDP-Gal donor binding site of human blood group B galactosyltransferase: design, synthesis, and characterization.
Schaefer K; Sindhuwinata N; Hackl T; Kötzler MP; Niemeyer FC; Palcic MM; Peters T; Meyer B
J Med Chem; 2013 Mar; 56(5):2150-4. PubMed ID: 23406460
[TBL] [Abstract][Full Text] [Related]
26. Blood group B galactosyltransferase: insights into substrate binding from NMR experiments.
Angulo J; Langpap B; Blume A; Biet T; Meyer B; Krishna NR; Peters H; Palcic MM; Peters T
J Am Chem Soc; 2006 Oct; 128(41):13529-38. PubMed ID: 17031966
[TBL] [Abstract][Full Text] [Related]
27. Rational design, synthesis, and characterization of novel inhibitors for human beta1,4-galactosyltransferase.
Takaya K; Nagahori N; Kurogochi M; Furuike T; Miura N; Monde K; Lee YC; Nishimura S
J Med Chem; 2005 Sep; 48(19):6054-65. PubMed ID: 16162007
[TBL] [Abstract][Full Text] [Related]
28. UDP-galactose 4-epimerase from Kluyveromyces fragilis: analysis of its hysteretic behavior during catalysis.
Nayar S; Brahma A; Barat B; Bhattacharyya D
Biochemistry; 2004 Aug; 43(31):10212-23. PubMed ID: 15287749
[TBL] [Abstract][Full Text] [Related]
29. Conformational changes induced by binding UDP-2F-galactose to alpha-1,3 galactosyltransferase- implications for catalysis.
Jamaluddin H; Tumbale P; Withers SG; Acharya KR; Brew K
J Mol Biol; 2007 Jun; 369(5):1270-81. PubMed ID: 17493636
[TBL] [Abstract][Full Text] [Related]
30. Synthesis of novel donor mimetics of UDP-Gal, UDP-GlcNAc, and UDP-GalNAc as potential transferase inhibitors.
Schäfer A; Thiem J
J Org Chem; 2000 Jan; 65(1):24-9. PubMed ID: 10813891
[TBL] [Abstract][Full Text] [Related]
31. Large-scale production of UDP-galactose and globotriose by coupling metabolically engineered bacteria.
Koizumi S; Endo T; Tabata K; Ozaki A
Nat Biotechnol; 1998 Sep; 16(9):847-50. PubMed ID: 9743118
[TBL] [Abstract][Full Text] [Related]
32. Effect of the Met344His mutation on the conformational dynamics of bovine beta-1,4-galactosyltransferase: crystal structure of the Met344His mutant in complex with chitobiose.
Ramakrishnan B; Boeggeman E; Qasba PK
Biochemistry; 2004 Oct; 43(39):12513-22. PubMed ID: 15449940
[TBL] [Abstract][Full Text] [Related]
33. Chemoenzymatic synthesis, inhibition studies, and X-ray crystallographic analysis of the phosphono analog of UDP-Galp as an inhibitor and mechanistic probe for UDP-galactopyranose mutase.
Partha SK; Sadeghi-Khomami A; Slowski K; Kotake T; Thomas NR; Jakeman DL; Sanders DA
J Mol Biol; 2010 Nov; 403(4):578-90. PubMed ID: 20850454
[TBL] [Abstract][Full Text] [Related]
34. A chemoenzymatic synthesis of UDP-(2-deoxy-2-fluoro)-galactose and evaluation of its interaction with galactosyltransferase.
Hayashi T; Murray BW; Wang R; Wong CH
Bioorg Med Chem; 1997 Mar; 5(3):497-500. PubMed ID: 9113327
[TBL] [Abstract][Full Text] [Related]
35. A new concept for glycosyltransferase inhibitors: nonionic mimics of the nucleotide donor of the human blood group B galactosyltransferase.
Schaefer K; Albers J; Sindhuwinata N; Peters T; Meyer B
Chembiochem; 2012 Feb; 13(3):443-50. PubMed ID: 22223604
[TBL] [Abstract][Full Text] [Related]
36. Target-assisted selection of galactosyltransferase binders from dynamic combinatorial libraries. An unexpected solution with restricted amounts of the enzyme.
Valade A; Urban D; Beau JM
Chembiochem; 2006 Jul; 7(7):1023-7. PubMed ID: 16715540
[No Abstract] [Full Text] [Related]
37. Affinity labeling of bovine colostrum galactosyltransferase with a uridine 5'-diphosphate derivative.
Powell JT; Brew K
Biochemistry; 1976 Aug; 15(16):3499-505. PubMed ID: 952873
[TBL] [Abstract][Full Text] [Related]
38. Analysis of glycosphingolipid glycosyltransferase products on TLC plates by combined storage phosphor and immunostaining techniques.
Stults CL; Sullivan MT; Macher BA; Johnston RF; Stack RJ
Anal Biochem; 1994 May; 219(1):61-70. PubMed ID: 8059957
[TBL] [Abstract][Full Text] [Related]
39. Synthetic UDP-galactofuranose analogs reveal critical enzyme-substrate interactions in GlfT2-catalyzed mycobacterial galactan assembly.
Poulin MB; Zhou R; Lowary TL
Org Biomol Chem; 2012 May; 10(20):4074-87. PubMed ID: 22499274
[TBL] [Abstract][Full Text] [Related]
40. Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I.
Ramakrishnan B; Boeggeman E; Qasba PK
Biochemistry; 2005 Mar; 44(9):3202-10. PubMed ID: 15736931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
